They studied 7 patients and reported that NSCLC patients with high PD-L1 expression had greater tumour uptake of [18F]AlF-NOTA-NF12 (SUVmax: 3.29, SUVmean: 2.75) than did those with low PD-L1 expression (SUVmax: 2.22, and SUVmean: 1.75). The gene discussed is CD274; the disease is neoplasm.